Vol 25, No 6 (2020)
Published online: 2020-11-01

open access

Page views 168
Article views/downloads 270
Get Citation

Connect on Social Media

Connect on Social Media

Approach to radiation therapy in the Jehovah’s Witness patient: An overview

James M. Jurica12, Jay A. Messer23, Bin S. Teh1, Brian E. Butler1, Andrew M. Farach1
DOI: 10.1016/j.rpor.2020.08.014
Rep Pract Oncol Radiother 2020;25(6):856-859.


Jehovah’s Witnesses are well-known in the medical community for their inability to accept blood products. Novel methods of treatment are often needed to avoid anemia and hematologic toxicity as inability to receive blood products may increase the risk of treatment related complications. We provide an overview of radiation treatment for Jehovah’s Witness patients with an emphasis on bone marrow sparing strategies with intensity modulated radiation therapy (IMRT) to minimize hematologic toxicity.

Article available in PDF format

View PDF Download PDF file

Reports of Practical Oncology and Radiotherapy